Sugi Predict

Sugi Predict / Compounds / SCHEMBL63069

SCHEMBL63069

SCHEMBL63069

CCCCC(CC)CC(=C(C(=O)O)C(=O)O)c1ccc(OC)cc1CC(CC)CCCC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TAS1R3 Q7RTX0 1/20 0.42
▸ TAS1R1 Q7RTX1 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.39
▸ TSHR P16473 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ CA2 P00918 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ MMP1 P03956 2/20 0.37
▸ MMP2 P08253 2/20 0.37
▸ MMP3 P08254 2/20 0.37
▸ HDAC3 O15379 1/20 0.37
▸ HDAC1 Q13547 1/20 0.37
▸ HDAC2 Q92769 1/20 0.37
▸ ALOX5 P09917 1/20 0.36
▸ PPARG P37231 1/20 0.36
▸ PPARA Q07869 1/20 0.36
▸ MMP9 P14780 1/20 0.36
▸ MMP13 P45452 1/20 0.36
▸ MEN1 O00255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3176164 0.83 TDP1 (0.48) TAS1R3TAS1R1TDP1ALDH1A1TSHR
SCHEMBL20548410 0.81 ALDH1A1 (0.48) ALDH1A1TSHRMAPK1CA2CYP3A4
SCHEMBL4730656 0.81 ALDH1A1 (0.54) TAS1R3TAS1R1TDP1ALDH1A1TSHR
SCHEMBL14841129 0.75 TDP1 (0.47) TAS1R3TAS1R1TDP1ALDH1A1TSHR
SCHEMBL1988390 0.75 AKR1C3 (0.48) ALDH1A1TSHRCA2NPC1RAB9A
SCHEMBL5449778 0.74 ALOX5 (0.35) TAS1R3TAS1R1TDP1ALDH1A1TSHR
SCHEMBL3209414 0.74 TDP1 (0.49) TAS1R3TAS1R1TDP1ALDH1A1MAPK1
SCHEMBL126603 0.74 TDP1 (0.49) TAS1R3TAS1R1TDP1ALDH1A1MAPK1
SCHEMBL28810041 0.73 PTGES (0.43) TSHRALOX5PPARGPPARA
SCHEMBL5748837 0.73 ALDH1A1 (0.34) TDP1ALDH1A1TSHRMAPK1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3329901-B1 UV FILTER CONTAINING COSMETIC FOAM MADE FROM AN EMULSION CONTAINING SODIUM CETEARYLSULFATE AND GLYCEROL MONOSTEARATE BEIERSDORF AG (DE) 2020-11-04 — — EP claimed
US-8282910-B2 Composition for skin or hair SHISEIDO COMPANY LTD. (JP) 2012-10-09 — — US claimed
US-20080181920-A1 COSMETIC PREPARATION AGAINST SKIN PIGMENTATION BEIERSDORF AG (DE) 2008-07-31 — — US claimed
US-20240335500-A1 CONTROLLING PRO-INFLAMMATORY MACROPHAGE PHENOTYPE THROUGH BIOFUNCTIONAL HYDROGEL DESIGN UNIV FLORIDA (US) 2024-10-10 — — US disclosed
CN-118382420-A Improving the water resistance of cosmetic compositions comprising ENSO letrozole 帝斯曼知识产权资产管理有限公司 2024-07-23 — — CN disclosed
CN-113164796-B Cosmetic composition comprising a specific hyperbranched copolymer and an anionic emulsifier 帝斯曼知识产权资产管理有限公司 2024-06-21 — — CN disclosed
CN-111867553-B Surface composition 帝斯曼知识产权资产管理有限公司 2024-06-07 — — CN disclosed
CN-114401708-B Topical compositions 帝斯曼知识产权资产管理有限公司 2024-01-23 — — CN disclosed
CN-116634989-A Reduction of viscosity of cosmetic compositions comprising bisprozole 帝斯曼知识产权资产管理有限公司 2023-08-22 — — CN disclosed
CN-116600777-A Increased solubilization of diethylaminohydroxybenzoyl hexyl benzoate 帝斯曼知识产权资产管理有限公司 2023-08-15 — — CN disclosed
CN-116583263-A Increased solubilization of Isobenzetriol 帝斯曼知识产权资产管理有限公司 2023-08-11 — — CN disclosed
EP-1521798-A1 SUNSCREENS DSM IP Assets B.V. (NL) 2005-04-13 — — EP disclosed
EP-1515694-A1 BENZOXAZOLE AND BENZODIAZOLE UV-A SUNSCREENS DSM IP Assets B.V. (NL) 2005-03-23 — — EP disclosed
US-20040176448-A1 Use of carnitine and/or one or more acyl-carnitines for producing cosmetic or dermatological preparations, which increase ceramide biosynthesis BEIERSDORF AG (DE) 2004-09-09 — — US disclosed
US-6723548-B2 ENZYMATIC POLYPEPTIDE FOR USE INTHE TREATMENT OF CELL MAINTENANCE, IMMUNOLOGICAL AND APOPTITIC DEFECTS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2004-04-20 — — US disclosed
US-6703032-B2 PICKERING EMULSIONS, COMPRISING AN OIL PHASE, A WATER PHASE, ONE TYPE OF MICROFINE PARTICLES WHICH DISPLAY BOTH HYDROPHILIC AND LIPOPHILIC PROPERTIES, DISPERSIBLE BOTH IN WATER AND IN OIL, A CYCLODEXTRIN AND ONE OR MORE EMULSIFIERS BEIERSDORF AG (DE) 2004-03-09 — — US disclosed
WO-2004007592-A1 SUNSCREENS DSM IP ASSETS B.V. (NL) 2004-01-22 — — WO disclosed
WO-2004000256-A1 BENZOXAZOLE AND BENZODIAZOLE UV-A SUNSCREENS DSM IP ASSETS B.V. (NL) 2003-12-31 — — WO disclosed
US-6613338-B1 Lipsticks, antiacne sticks, sunscreen sticks and eyeshadow sticks, with a high water content, characterized in that they comprise a lipid phase, which comprises at least one oil component at least one wax component optionally other BEIERSDORF AG (DE) 2003-09-02 — — US disclosed
US-5750124-A W/O/W emulsions BEIERSDORF AG (DE) 1998-05-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040176448-A1 Use of carnitine and/or one or more acyl-carnitines for producing cosmetic or dermatological preparations, which increase ceramide biosynthesis CERS2, CRAT, CPT2 TAS1R3 3011/4885TAS1R1 2589/4885TDP1 2747/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.